AstraZeneca receives positive NICE recommendations for lung cancer treatment

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across England and Wales.

Should the Way We Describe MS Progression Change?

A recent survey conducted by the International Advisory Committee on Clinical Trials in Multiple Sclerosis (MS), aimed to assess the perspective of the scientific and

November 7, 2023

Concussion history identified as key risk factor for maternal mental illness

People with a history of concussion face a 25% higher risk of having severe mental health issues after childbirth, according to a new study from

November 4, 2024

New study finds maternal vaccine and monoclonal antibody effective against RSV in infants

The impact and cost-effectiveness of maternal vaccination (MV) to long-acting monoclonal antibody (la-mAB) therapy.

January 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.